N
Nontombi Marylucy Mbelle
Researcher at University of Pretoria
Publications - 60
Citations - 2836
Nontombi Marylucy Mbelle is an academic researcher from University of Pretoria. The author has contributed to research in topics: Colistin & Resistome. The author has an hindex of 18, co-authored 57 publications receiving 2434 citations. Previous affiliations of Nontombi Marylucy Mbelle include University of the Witwatersrand & National Health Laboratory Service.
Papers
More filters
Journal ArticleDOI
A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.
Keith P. Klugman,Keith P. Klugman,Shabir A. Madhi,Robin E. Huebner,Robert Kohberger,Nontombi Marylucy Mbelle,Nathaniel F. Pierce +6 more
TL;DR: Vaccination with a 9-valent pneumococcal conjugate vaccine reduced the incidence of radiologically confirmed pneumonia among children with and those without HIV infection.
Journal ArticleDOI
Immunogenicity and Impact on Nasopharyngeal Carriage of a Nonavalent Pneumococcal Conjugate Vaccine
TL;DR: The safety, immunogenicity, and impact on carriage of a nonvalent pneumococcal vaccine given at ages 6, 10, and 14 weeks were examined in a double-blind, randomized, placebo-controlled trial in 500 infants in Soweto, South Africa.
Journal ArticleDOI
Plasmid evolution in carbapenemase-producing Enterobacteriaceae: a review
TL;DR: A literature search for English research papers, published between 2013 and 2018, reporting on plasmid‐mediated carbapenem resistance saw a rise in both carbapanemase types and associated plasmID replicon groups was seen, with China, Canada, and the United States recording a higher increase than other countries.
Journal ArticleDOI
Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection.
Shabir A. Madhi,Karen Petersen,Manikant Khoosal,Robin E. Huebner,Nontombi Marylucy Mbelle,Rosalia Mothupi,Haroon Saloojee,Heather Crewe-Brown,Keith P. Klugman +8 more
TL;DR: Although the Hib conjugate vaccine was less effective among HIV-1-infected than among uninfected children, it was 83% effective in preventing overall invasive Hib disease and therefore should be considered for inclusion in the routine vaccination schedule by other African countries.
Journal ArticleDOI
Klebsiella pneumoniae ST307 with blaOXA-181, South Africa, 2014–2016
Michelle Lowe,Michelle Lowe,Marleen M. Kock,Marleen M. Kock,Jennifer Coetzee,Ebrahim Hoosien,Gisele Peirano,Kathy-Anne Strydom,Kathy-Anne Strydom,Marthie M. Ehlers,Marthie M. Ehlers,Nontombi Marylucy Mbelle,Nontombi Marylucy Mbelle,Elena Shashkina,David B. Haslam,Puneet Dhawan,Robert J. Donnelly,Liang Chen,Liang Chen,Barry N. Kreiswirth,Johann D.D. Pitout,Johann D.D. Pitout +21 more
TL;DR: The rapid expansion of K. pneumoniae ST307 was most likely due to intrahospital, interhospital, intercity, and interprovince movements of patients, and the importance of molecular surveillance for tracking emerging antimicrobial clones is highlighted.